Z
0.950
-0.04 (-4.04%)
Market Trend
Short Term | Medium Term | ||
Industry | Medical Instruments & Supplies (US) | Mixed | Bearish |
Medical Instruments & Supplies (Global) | Mixed | Mixed | |
Stock | Zentek Ltd. | Mixed | Mixed |
Stockmoo Score
-0.7
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases. |
|
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
Investment Style | Small Value |
Ownership
Name | Date | Shares Held |
---|---|---|
Carolina Wealth Advisors, Llc | 30 Jun 2024 | 3,130 |
Aspect Partners, Llc | 30 Jun 2024 | 1,666 |
No data within this time range.
No data within this time range.
Date | Type | Details |
---|---|---|
19 Aug 2024 | Announcement | Zentek Announces Closing of Non-Brokered Private Placement of Units |
14 Aug 2024 | Announcement | Zentek Announces Upsize to Non-Brokered Private Placement of Units |
14 Aug 2024 | Announcement | Zentek Announces Normal Course Issuer Bid |
08 Aug 2024 | Announcement | Zentek Announces Preliminary Battery Results and University of Toronto Receives NSERC Mission Alliance Grant to Optimize Graphite for Battery Anode Use |
24 Jul 2024 | Announcement | Zentek Launches National Sampling Program for ZenGUARD(TM) Antimicrobial Surgical Masks |
23 Jul 2024 | Announcement | Zentek Announces Non-Brokered Private Placement of Units for up to $3 Million |
17 Jul 2024 | Announcement | Zentek Subsidiary Albany Graphite Corp. Achieves Five Nines Purity for Albany Graphite |
21 Jun 2024 | Announcement | Zentek Announces Grant of Stock Options |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2024 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |